| Literature DB >> 33984031 |
Maliwan Oofuvong1, Alan Frederick Geater2, Virasakdi Chongsuvivatwong2, Thavat Chanchayanon1, Bussarin Sriyanaluk1, Boonthida Suwanrat1, Kanjana Nuanjun1.
Abstract
OBJECTIVE: We examined the consequences of perioperative respiratory event (PRE) in terms of hospitalization and hospital cost in children who underwent ambulatory surgery.Entities:
Year: 2021 PMID: 33984031 PMCID: PMC8118274 DOI: 10.1371/journal.pone.0251433
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the study.
Characteristics and severity of perioperative respiratory events.
| Characteristic | Severity | p-value | ||
|---|---|---|---|---|
| Mild (SpO2> 94%) ( | Moderate (SpO2 86–94%) ( | Severe (SpO2 < 86%) ( | ||
| | <0.001 | |||
| Desaturation | 0 (0) | 34 (77.3) | 6 (42.9) | |
| Stridor | 4 (80) | 2 (4.5) | 2 (14.3) | |
| Bronchospasm | 1 (20) | 3 (6.8) | 1 (17.1) | |
| Laryngospasm | 0 (0) | 3 (6.8) | 2 (14.3) | |
| Endotracheal tube displacement | 0 (0) | 2 (4.5) | 3 (21.4) | |
| 0.004 | ||||
| At intraoperative only | 2 (40) | 26 (59.1) | 8 (57.1) | |
| At PACU only | 3 (60) | 18 (40.9) | 2 (14.3) | |
| Both | 0 (0) | 0 (0) | 4 (28.6) | |
| Time to event (min) | 80 [70, 90] | 53 [10, 125] | 55 [19, 74] | 0.598 |
| Duration of event (min) | 5.0 [1.0, 5.0] | 1.0 [1.0, 2.0] | 1.0 [1.0, 4.2] | 0.599 |
| Range (min) | 1.0–70.0 | 1.0–50.0 | 1.0–35.0 | |
Note: The values are presented as the number of patients (%) per group or the median [interquartile range]. SpO2, Oxygen saturation; PACU, postanesthesia care unit.
Comparison of characteristics of children having general anesthesia with and without PRE.
| Variables | PRE (n = 63) | Non-PRE (n = 249) | p-value |
|---|---|---|---|
| Age (months) | 44 [29.5, 92.0] | 60.5 [37.0, 92.5] | 0.112 |
| Age (months) | 0.965 | ||
| < 12 | 3 (4.8) | 10 (4.0) | |
| 12–72 | 38 (60.3) | 152 (61.0) | |
| > 72 | 22 (34.9) | 87 (34.9) | |
| Male | 42 (66.7) | 180 (72.3) | 0.469 |
| Anthropometry | |||
| Weight (kg) | 14.0 [11.8, 22.7] | 16.8 [13.0, 22.6] | 0.137 |
| Height (cm), mean (SD) | 104.2 (23.7) | 107.8 (21.4) | 0.238 |
| Body mass index (kg/m2) | 15.7 [14.4, 18.6] | 15.1 [13.7, 17.4] | 0.089 |
| Obesity | 10 (15.9) | 26 (10.4) | 0.325 |
| Respiratory-related variables | |||
| Upper respiratory tract infection | 11 (17.5) | 24 (9.6) | 0.125 |
| Smoking | 32 (50.8) | 125 (50.2) | 1.00 |
| Snoring | 18 (28.6) | 75 (30.1) | 0.931 |
| Type of surgery/procedure | 0.723 | ||
| Urology | 25 (39.7) | 108 (43.4) | |
| Ear-nose-throat | 17 (27.0) | 51 (20.5) | |
| Eye | 10 (15.9) | 46 (18.5) | |
| Others | 11 (17.5) | 44 (17.7) | |
| Preoperative planned admission | 19 (30.2) | 53 (21.3) | 0.185 |
| ASA classification | 0.028 | ||
| 1 | 12 (19.0) | 90 (36.1) | |
| 2 | 48 (76.2) | 145 (58.2) | |
| 3 | 3 (4.8) | 14 (5.6) | |
| Type of anesthesia | 0.932 | ||
| GA alone | 40 (63.5) | 161 (64.7) | |
| GA with caudal block | 16 (25.4) | 58 (23.3) | |
| GA with peripheral nerve block | 7 (11.1) | 30 (12.0) | |
| Airway management | 0.427 | ||
| Mask | 27 (42.9) | 87 (34.9) | |
| Laryngeal mask airway | 8 (12.7) | 44 (17.7) | |
| Endotracheal tube | 28 (44.4) | 118 (47.4) | |
| Induction agent | 0.754 | ||
| Sevoflurane | 55 (87.3) | 211 (84.7) | |
| Propofol | 8 (12.7) | 38 (15.3) | |
| Intubating agent | 0.403 | ||
| Succinylcholine | 3 (4.8) | 7 (2.8) | |
| NDMR | 17 (2.7) | 46 (18.5) | |
| Sevoflurane | 5 (7.9) | 16 (6.4) | |
| Propofol | 2 (3.2) | 10 (4.0) | |
| No endotracheal tube | 36 (57.1) | 170 (68.3) | |
| Inhalation agent | 0.262 | ||
| Sevoflurane | 58 (92.1) | 237 (95.2) | |
| Isoflurane/Desflurane | 2 (3.2) | 2 (0.8) | |
| None | 3 (4.8) | 10 (4.0) | |
| Gas mixed with oxygen | 0.315 | ||
| Air | 53 (84.1) | 216 (86.7) | |
| N2O | 10 (15.9) | 27 (10.8) | |
| 100% O2 | 0 (0.0) | 6 (2.4) | |
| Narcotic | 0.764 | ||
| Intravenous fentanyl | 61 (96.8) | 236 (94.8) | |
| Caudal narcotic | 2 (3.2) | 8 (3.2) | |
| None | 0 (0.0) | 5 (2.0) | |
| Payment system variable | |||
| Type of payment | 0.284 | ||
| Universal Coverage | 42 (66.7) | 172 (69.1) | |
| CGD | 13 (20.6) | 41 (16.5) | |
| Self-pay | 5 (7.9) | 32 (12.9) | |
| Government corporation | 2 (3.2) | 3 (1.2) | |
| Private insurance | 1 (1.6) | 1 (0.4) |
Note: The values are presented as the number of patients (%) per group and the median [interquartile range] if not stated otherwise, Others = mass excision/gastroscopy. ASA, American Society of Anesthesiologist; CGD, The Comptroller General’s Department; ETT, Endotracheal tube; NDMR, Non-depolarizing muscle relaxant; PNB. Peripheral nerve block; RA, Regional anesthesia; PRE, Perioperative respiratory event.
Fig 2The number of days of hospitalization post-surgery among non-PRE (N = 249) and PRE group (N = 63).
PRE, perioperative respiratory events. For PRE group, n = 38 in day 0, n = 15 in day 1, n = 7 in day 2, n = 3 in day 5.
Outcome of interest of children having general anesthesia with and without PRE.
| Variables | PRE (n = 63) | Non-PRE (n = 249) | Mean differences (95% CI) | p-value |
|---|---|---|---|---|
| Duration of anesthesia (min) | 80 [60, 113] | 65 [40, 85] | 24.2 (8.5 to 39.8) | < 0.001 |
| PACU stay (min) | 70 [50, 100] | 65 [45, 100] | 0.45 (–11.4 to 12.3) | 0.615 |
| Admission outcome | < 0.001 | |||
| Discharge same day | 36 (57.1) | 196 (78.7) | ||
| Planned admission | 19 (30.2) | 53 (21.3) | – | |
| Unplanned admission | 8 (12.7) | 0 (0) | ||
| Postoperative oxygen device | 5 (7.9) | 0 (0.0) | – | < 0.001 |
| Postoperative fever | 1 (1.6) | 0 (0.0) | – | 0.202 |
| Length of stay (days) | 0 [0, 1.0] | 0 [0, 0] | 0.29 (–0.03 to 0.62) | 0.004 |
| Prolonged length of stay | 15 (23.8) | 20 (8.0) | – | < 0.001 |
| Hospital cost | 4,096 [3,320, 6,046] | 3,632 [2,272, 4,795] | 1,015.0 (257.9 to 1772.1) | 0.006 |
| Hospital charge | 10,240 [8,301, 15,115] | 9,080 [5,680, 11,988] | 2,537.5 (644.7 to 4,430.3) | 0.006 |
| Accommodation | 0 [0, 300] | 0 [0, 0] | 84.3 (–18.1 to 186.6) | 0.008 |
| Meal | 0 [0, 140] | 0 [0, 0] | 52.5 (–13.9 to 118.9) | 0.018 |
| Medication | 64 [21, 491] | 49 [17, 302] | 151.3 (–52.0 to 354.6) | 0.095 |
| X-ray and laboratory | 0 [0, 220] | 0 [0, 0] | 42.6 (–120.0 to 205.3) | 0.045 |
| Oxygen therapy (includes suction) | 133.2 (296.6) | 88.3 (208.2) | 44.9 (–34.0 to 123.8) | 0.261 |
| Surgical charge | 3,900 [2,700, 4,825] | 3,900 [1,900, 4,500] | 584 (–49.5 to 1218.3) | 0.108 |
| Procedure related to surgery | 57.3 (290.4) | 38.6 (144.0) | 18.7 (–56.6 to 93.9) | 0.622 |
| Anesthesia charge | 1,900 [1,400, 3,075] | 1,400 [1,400, 2,350] | 525.6 (104.9 to 946.3) | 0.006 |
| Procedure related to anesthesia | 950 [360, 1,150] | 950 [460, 1,175] | -57.7 (–205.8 to 90.4) | 0.248 |
| Material charge | 2,092 [1,115, 3,754] | 1,902 [602, 2,527] | 945.2 (–21.7 to 1,912.1) | 0.089 |
| Nursing care service | 50 [50, 500] | 50 [50, 50] | 130.7 (–34.9 to 296.21) | 0.002 |
| Excess hospital charge | 6,437 [4,818, 10,157] | 5,279 [3,746, 6,562] | 1953.1 (511.2 to 3395.0) | 0.002 |
Note: The values are presented as the median [interquartile range] and the number of patients (%) per group
§ displayed with mean (SD) instead of median [interquartile range] because these variables had P25, P50, P75 being zero
*Wilcoxon rank sum test
**Chi-square test. PRE, perioperative respiratory event; PACU, Postanesthesia care unit.
a p < 0.05 by unpaired t-test
$31.25 baht per U.S. dollar
bcalculated from hospital charge × 0.4
ccalculated from hospital charge–surgical charge. All costs are in Thai baht.
Net revenue and contribution margin among types of surgery between PRE and non-PRE (N = 312).
| Type of surgery | Without PRE (baht) | With ≥ 1 PRE (baht) | Difference (PRE vs non-PRE) in contribution margin per patient, baht | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of patients | Net revenue | Net revenue per patient (95% CI) | Contribution margin | No. of patients | Net revenue | Net revenue per patient (95% CI) | Contribution margin | ||
| Minor eye surgery | 28 | 126,093 | 4,503 (3,620 to 5,380) | 2,702 (2,170 to 3,230) | 5 | 23,491 | 4,698 (3,780 to 5,610) | 2,819 (2,270 to 3,370) | 117 (–721 to 955) |
| Eye muscle resection | 13 | 160,663 | 12,359 (11,600 to 13,100) | 7,415 (6,940 to 7,890) | 2 | 26,567 | 13,285 (12,400 to 14,100) | 7,971 (7,470 to 8,470) | 556 (–500 to 1,611) |
| Vitreoretinal surgery | 5 | 121,606 | 24,321 (9,720 to 38,900) | 14,593 (5,830 to 23,400) | 3 | 93,068 | 31,023 (26,100 to 35,900) | 18,614 (15,700 to 21,500) | 4,021 (–8,230 to 16,272) |
| Tongue tie operation | 17 | 80,809 | 4,754 (4,550 to 4,960) | 2,852 (2,730 to 2,970) | 2 | 8,794 | 4,397 (2,310 to 6,490) | 2,638 (2,210 to 3,060) | –214 (–2,263 to 1,835) |
| Tonsillectomy | 4 | 43,639 | 10,910 (9,810 to 12,000) | 6,546 (5,880 to 7,210) | 4 | 42,297 | 10,574 (8,160 to 13,000) | 6,345 (4,900 to 7,780) | –201 (–2,409 to 2,006) |
| Direct laryngoscopy and bronchoscopy | 22 | 280,649 | 12,757 (10,500 to 15,000) | 7,654 (6,310 to 8,990) | 7 | 115,896 | 16,557 (14,100 to 19,100) | 9,934 (8,430 to 11,400) | 2,279 (106 to 4,454) |
| Ear surgery | 5 | 70,192 | 14,038 (7,350 to 20,700) | 8,423 (4,400 to 12,400) | 4 | 54,975 | 13,744 (2,940 to 24,500) | 8,246 (1,780 to 14,700) | -177 (-10,054 to 9,700) |
| Urethral dilatation | 13 | 57,485 | 4,422 (3,640 to 5,200) | 2,653 (2,190 to 3,120) | 2 | 8,420 | 4,210 (3,090 to 5,330) | 2,526 (1,860 to 3,200) | –127 (–1,799 to 1,545) |
| Minor urologic surgery | 69 | 653,450 | 9,470 (9,070 to 9,870) | 5,682 (5,440 to 5,920) | 16 | 158,622 | 9,914 (8,880 to 10,900) | 5,948 (5,330 to 6,560) | 266 (–438 to 971) |
| Urethroplasty | 27 | 406,301 | 15,048 (13,700 to 16,300) | 9,029 (8,250 to 9,810) | 7 | 120,950 | 17,279 (13,900 to 20,700) | 10,367 (8,330 to 12,400) | 1,338 (–1,245 to 3,921) |
| Excision superficial mass | 30 | 286,588 | 9,553 (7,270 to 11,800) | 5,732 (4,360 to 7,100) | 9 | 102,791 | 11,421 (7,300–15,500) | 6,853 (4,380 to 9,320) | 1,121 (–1,987 to 4,230) |
| Gastroscopy | 16 | 140,082 | 8,755 (7,040 to 10,500) | 5,253 (4,220 to 6,280) | 2 | 18,191 | 9,096 (6,860 to 11,300) | 5,457 (4,110 to 6,810) | 204 (–2,924 to 3,332)) |
| Total | 249 | 2,427,557 | 9,749 (9,050 to 10,400) | 5,850 (5,430 to 6,270) | 63 | 774,064 | 12,287 (10,600 to 14,000) | 7,372 (6,330 to 8,410) | 1,523 (387 to 2,658) |
31.25 baht per U.S. dollar
aeye examination/change eye prothesis
bcircumcision/hydrocelectomy/herniotomy
ccalculated from hospital charge × 0.6
*p <0.05 by unpaired t-test
**p <0.01 by unpaired t-test.
Predictors of excess hospital cost, length of stay and prolonged length of stay (N = 312).
| Variables | Geometric mean | p-value | Length of stay, Mean (SD) | p-value | Prolonged length of stay, N (% | p-value | |
|---|---|---|---|---|---|---|---|
| Yes (n = 35) | No (n = 277) | ||||||
| PRE | 0.003 | 0.077 | <0.001 | ||||
| Yes (n = 63) | 4315.64 (2.44) | 0.70 (1.19) | 15 (23.8) | 48 (76.2) | |||
| No (n = 249) | 2951.30 (2.34) | 0.41 (1.05) | 20 (8.0) | 229 (92.0) | |||
| Severity of PRE | 0.005 | 0.141 | <0.001 | ||||
| Non-PRE (n = 249) | 2951.30 (2.34) | 0.41 (1.05) | 20 (8.0) | 229 (92.0) | |||
| Mild to moderate (SpO2 86–99%) (n = 49) | 4536.90 (2.41) | 0.74 (1.29) | 10 (20.4) | 39 (79.6) | |||
| Severe (SpO2 < 86%) (n = 14) | 3604.72 (2.48) | 0.57 (0.76) | 5 (35.7) | 9 (64.3) | |||
| Preoperative planned admission | <0.001 | <0.001 | <0.001 | ||||
| Yes (n = 72) | 6836.29 (1.92) | 1.89 (1.53) | 27 (37.5) | 45 (62.5) | |||
| No (n = 240) | 2540.21 (2.20) | 0.04 (0.21) | 8 (3.3) | 232 (96.7) | |||
| Age (years) | <0.001 | 0.003 | 0.018 | ||||
| ≤ 6 (n = 203) | 2697.28 (2.34) | 0.33 (0.93) | 16 (7.9) | 187 (92.1) | |||
| > 6 (n = 109) | 4402.82 (2.25) | 0.72 (1.30) | 19 (17.4) | 90 (82.6) | |||
| Obesity | 0.904 | 0.968 | 0.398 | ||||
| Yes (n = 36) | 3165.29 (2.10) | 0.47 (1.18) | 2 (5.6) | 34 (94.4) | |||
| No (n = 276) | 3197.10 (2.41) | 0.46 (1.07) | 33 (12.0) | 243 (88.0) | |||
| Upper respiratory tract infection | 0.632 | 0.344 | 0.780 | ||||
| Yes (n = 35) | 3394.8 (2.16) | 0.63 (1.52) | 3 (8.6) | 32 (91.4) | |||
| No (n = 277) | 3165.29 (2.41) | 0.44 (1.02) | 32 (11.6) | 245 (88.4) | |||
| History of snoring | 0.767 | 0.671 | 0.715 | ||||
| Yes (n = 93) | 3261.69 (2.53) | 0.51 (1.11) | 9 (9.7) | 84 (90.3) | |||
| No (n = 219) | 3165.29 (2.32) | 0.45 (1.08) | 26 (11.9) | 193 (88.1) | |||
| Type of surgery | <0.0001 | 0.301 | 0.884 | ||||
| Urology (n = 133) | 3677.54 (1.77) | 0.38 (1.02) | 13 (9.8) | 120 (90.2) | |||
| ENT (n = 68) | 3533.34 (2.77) | 0.40 (0.63) | 9 (13.2) | 59 (86.8) | |||
| Eye (n = 56) | 1978.31 (3.22) | 0.70 (1.17) | 7 (12.5) | 49 (87.5) | |||
| Others (n = 55) | 3294.47 (2.12) | 0.51 (1.50) | 6 (10.9) | 49 (89.1) | |||
| ASA classification | 0.118 | 0.038 | 0.004 | ||||
| 1 (n = 102) | 2951.30 (2.27) | 0.43 (1.09) | 8 (7.8) | 94 (92.2) | |||
| 2 (n = 193) | 3229.23 (2.41) | 0.43 (0.94) | 21 (10.9) | 172 (89.1) | |||
| 3 (n = 17) | 4722.06 (2.56) | 1.12 (2.09) | 6 (35.3) | 11 (64.7) | |||
| Type of GA | 0.0004 | 0.687 | 0.804 | ||||
| GA alone (n = 201) | 2779.43 (2.72) | 0.49 (1.07) | 23 (11.4) | 178 (88.6) | |||
| GA with caudal block (n = 74) | 4315.64 (1.58) | 0.46 (1.17) | 9 (12.2) | 65 (87.8) | |||
| GA with PNB (n = 37) | 3827.63 (1.55) | 0.32 (0.97) | 3 (8.1) | 34 (91.9) | |||
| Induction agents | 0.015 | 0.008 | <0.001 | ||||
| Sevoflurane (n = 266) | 3010.92 (2.29) | 0.34 (0.77) | 22 (8.3) | 244 (91.7) | |||
| Propofol (n = 46) | 4447.07 (2.69) | 1.17 (2.01) | 13 (28.3) | 33 (71.7) | |||
| Airway management | <0.001 | 0.001 | 0.011 | ||||
| Mask (n = 52) | 972.63 (1.82) | 0.02 (1.40) | 0 (0) | 52 (100) | |||
| LMA (n = 146) | 3944.19 (1.73) | 0.45 (1.05) | 17 (11.6) | 129 (88.4) | |||
| ETT (n = 114) | 4188.09 (2.36) | 0.69 (1.29) | 18 (15.8) | 96 (84.2) | |||
| Narcotic use | <0.001 | 0.281 | 0.488 | ||||
| None (n = 5) | 566.80 (1.55) | 0 (0) | 0 (0) | 5 (100) | |||
| IV fentanyl (n = 297) | 3229.23 (2.34) | 0.46 (1.07) | 33 (11.1) | 264 (88.9) | |||
| Caudal narcotic (n = 10) | 5597.08 (1.79) | 0.90 (1.60) | 2 (20.0) | 8 (80.0) | |||
| Type of payment | 0.012 | 0.025 | 0.124 | ||||
| UC (n = 214) | 3468.38 (2.41) | 0.49 (1.10) | 26 (12.1) | 188 (87.9) | |||
| CGD (n = 54) | 2864.07 (2.23) | 0.44 (1.06) | 6 (11.1) | 48 (88.9) | |||
| Self-pay (n = 37) | 2164.62 (2.23) | 0.16 (0.55) | 1 (2.7) | 36 (97.3) | |||
| Government corporation (n = 5) | 5486.25 (2.72) | 1.80 (2.49) | 2 (40.0) | 3 (60.0) | |||
| Private insurance (n = 2) | 5115.34 (1.21) | 1.00 (0) | 0 (0) | 2 (100) | |||
* row percent
a p <0.05 by unpaired t- test
b p <0.05 by F test statistic
c p <0.05 by Chi-square test
G exponential of the log of the excess cost, Others = mass excision/gastroscopy, ASA, American Society of Anesthesiologist; ENT, Ear-nose-throat; GA, General anesthesia; GSD, Geometric standard deviation; PNB, Peripheral nerve block; LMA, Laryngeal mask airway; ETT, Endotracheal tube; IV intravenous; UC, Universal coverage; CGD, Comptroller General’s Department; PRE, Perioperative respiratory event; SpO2, Oxygen saturation.
Multiple logistic regression by total effect model predicting relative probability of prolonged length of stay and log excess hospital cost (N = 312).
| Planned admission and non-PRE | 1a | <0.001 |
| Planned admission and PRE | 1.69 (0.49, 5.78)a | |
| Unplanned admission and non-PRE | 0.011 (0.002, 0.07)b | |
| Unplanned admission and PRE | 0.26 (0.08, 0.87)c | |
| Planned admission and non-PRE | 1a | <0.001 |
| Planned admission and mild to moderate PRE | 1.22 (0.32, 4.63)a | |
| Planned admission and severe PRE | 7.56 (0.52, 110.0) a | |
| Unplanned admission and non-PRE | 0.011 (0.002, 0.067)b | |
| Unplanned admission and mild to moderate PRE | 0.19 (0.04, 0.81)c | |
| Unplanned admission and severe PRE | 0.51 (0.09, 2.81)ac | |
| PRE (ref = non-PRE) | 1.35 (1.13, 1.62) | 0.001 |
| Severity of PRE (ref = Non-PRE) | 1a | 0.004 |
| Mild to moderate | 1.39 (1.14, 1.68)b | |
| Severe | 1.23 (0.87, 1.73)ab | |
*Likelihood ratio test
**F-test. PRE, Perioperative respiratory event. ref: reference group.
†Minimally sufficient adjusted set: Age, American Society of Anesthesiologists classification, snore, type of surgery, type of payment.
‡Minimally sufficient adjusted set: Age, American Society of Anesthesiologists classification, obesity, snore, type of surgery, airway management, type of payment. Odd ratios within columns and variables that have no superscript (abc) in common differ significantly at p <0.05 (Wald test).